Clinical Trials Logo

Clinical Trial Summary

Coronary heart disease (CHD) is a public health care challenge. There are three types of treatment for CHD, medication, percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG). However, some end-stage CHD patients lost the chance to get those treatment. Cardiac shock wave therapy (CSWT) is a new developed therapy for these patients, which is used in tens of countries all over the world. Safety, invasiveness, effectiveness is its advantage. Ischemia condition can be improved after CSWT. There are only three cities in China run the program of CSWT, which are Kunming, Beijing and Shanghai. The investigators designed a randomized double-blind study to evaluate the effectiveness and safety of CSWT.


Clinical Trial Description

Coronary heart disease (CHD) is a public health care challenge, which lead to 3.5 millions of people died in China every year. There are three types of treatment for CHD, medication, percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG). However, some end-stage CHD patients with severe cardiac ischemia lost the chance to get those treatment. Their quality of life is influenced by recurrent angina. Cardiac shock wave therapy (CSWT) is a new developed therapy for these patients, which is used in tens of countries all over the world. German and Japan are the countries earliest used CSWT. Safety, invasiveness, effectiveness is its advantage. Ischemia condition can be improved after CSWT by objective examination. New small vessels generation on ischemia area was found on mice and pig model. There are only three cities in China run the program of CSWT, that are Kunming, Beijing and Shanghai. Beijing hospital has the only CSWT machine in Beijing. The investigators designed a randomized double-blind study to evaluate the effectiveness and safety of CSWT. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03053128
Study type Interventional
Source Beijing Hospital
Contact
Status Completed
Phase N/A
Start date January 20, 2017
Completion date November 20, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06154473 - Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
Completed NCT03203057 - Induced Myocardial Ischemia: a Serial Troponin T and Troponin I Measurements N/A
Active, not recruiting NCT06235424 - Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement Phase 4
Completed NCT03859466 - Safety and Efficacy of Cardiac Shockwave Therapy in Patients Undergoing Coronary Artery Bypass Grafting N/A
Recruiting NCT04749212 - Perioperative Troponin I and NT Pro-BNP in Lung Resection
Recruiting NCT03798652 - Improved Prediction of Functional Recovery After Revascularisation Using Combined Assessment of Myocardial Ischaemia and Viability by CMR - Pilot Study
Recruiting NCT05726604 - 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy N/A
Completed NCT04458155 - Li-Hep vs. Non-Li-Hep Coated Transfer Device
Completed NCT02055443 - Myocardial Ischemia Detection for Early Identification of Patients With Ischemic Chest Pain N/A
Completed NCT03433963 - The Use of L-arginine to Mitigate the Cardiovascular Effects of Exposure to Traffic-related Air Pollution N/A
Recruiting NCT05757947 - Study of the No-touch Saphenous Vein Graft N/A
Completed NCT05164640 - Ischemia in Patients With Non-obstructive Disease (INOCA) in Italy INOCA IT Multicenter Registry" N/A
Completed NCT03642730 - Interactive Guided Ultrasound Examinations Done by Non-experts of Ultrasound Imaging N/A
Recruiting NCT05006183 - Instantaneous Wave-free Ratio Guidance Strategy Evaluation in the Treatment of Multivessel Acute Coronary Syndrome. N/A
Active, not recruiting NCT05453097 - Prognostic Value of the Selvester QRS Score for Perioperative Myocardial Injury Following Non-cardiac Surgery
Recruiting NCT03800082 - Development and Usability Testing of a Progressive WebApp for Women With Heart Disease N/A
Completed NCT03857503 - Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)